Accumulating evidence has demonstrated that ROR is upregulated in multiple types of cancer and associated with tumor metastasis, EMT program, drug resistance, and stem cell-like characteristic promotion by various regulatory mechanisms in ovarian, lung, breast cancer, hepatocellular cancer, gastric cancer, and so on (146, 147). The gene discussed is LINC-ROR; the disease is cancer.